1. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997 Aug; 388(6642): 539-47. doi:10.1038/41483 2. Roesler BM, Rabelo-Gonçalves EM, Zeitune JM. Virulence factors of Helicobacter pylori: A review. Clin Med Insights Gastroenterol. 2014 Mar; 7: 9-17. doi:10.4137/CGast.S13760 3. Ruggiero P, Censini S. Helicobacter pylori: A brief history of a still lacking vaccine. Diseases. 2014; 2(2): 187-208. doi:10.3390/diseases2020187 4. Souod N, Kargar M, Doosti A, Ranjbar R, Sarshar M. Genetic analysis of cagA and vacA Genes in Helicobacter Pylori isolates and their relationship with gastroduodenal diseases in the West of Iran. Iran Red Crescent Med J. 2013 May; 15(5): 371-75. doi:10.5812/ircmj.3732 5. Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014 Apr; 345(2): 196-202. doi:10.1016/j.canlet.2013.08.016 6. Rahimian G, Sanei MH, Shirzad H, Azadegan-Dehkordi F, Taghikhani A, Salimzadeh L, et al. Virulence factors of Helicobacter pylori vacA increase markedly gastric mucosal TGF-alpha1 mRNA expression in gastritis patients. Microb Pathog. 2014 Feb-Mar; 67-68: 1-7. doi:10.1016/j.micpath.2013.12.006 7. Doosti A, Rahimian G, Nassiri J, Yavari-Forushani P. [Prevalence of the cagA-positive Helicobacter pylori strains isolated from gastric biopsy specimens in Shahrekord]. Armaghane Danesh. 2007; 12(1): 29-38. [Article in Persian] 8. Michie KA, Boysen A, Low HH, Møller-Jensen J, Löwe J. LeoA, B and C from enterotoxigenic Escherichia coli (ETEC) are bacterial dynamins. PLoS One. 2014 Sep; 9(9): e107211. doi:10.1371/journal.pone.0107211 9. Brown EA, Hardwidge PR. Biochemical characterization of the enterotoxigenic Escherichia coli LeoA protein. Microbiology. 2007 Nov; 153(Pt 11): 3776-84. doi:10.1099/mic.0.2007/009084-0 10. Vaise Malekshahi Z, Hatef Salmanian A, Ebrahimizadeh W, Amiri Javid Sh. [The effect of DNA vaccine induced IgY against C-Urease in mice infected with Helicobacter pylori]. Med J Tabriz Univ Med Sci. 2012; 34(5): 79-86. [Article in Persian] 11. Hajikhani B, Najar-Piraye S, Soliman-Jahi H, Zuhair MH. [Cloning, expression, purification and study of the antigenicity of Helicobacter pylori UreB332-HpaA protein]. Modares Journal of Medical Sciences. 2013; 13(2): 1-10. [Article in Persian] 12. Jalali Kondori B, Asadi MH, Azemati F. [Subcloning of NGF Gene into pSecTag2/Hygro Secretory Vector and Expression in PC12 Cell Line]. Shefaye Khatam. 2014; 3(1): 21-28. [Article in Persian] 13. Del Giudice G, Covacci A, Telford JL, Montecucco C, Rappuoli R. The design of vaccines against Helicobacter pylori and their development. Annu Rev Immunol. 2001; 19: 523-63. doi:10.1146/annurev.immunol.19.1.523 14. Every AL, Stent A, Moloney MB, Ng GZ, Skene CD, Edwards SJ, et al. Evaluation of superoxide dismutase from Helicobacter pylori as a protective vaccine antigen. Vaccine. 2011 Feb; 29(7): 1514-18. doi:10.1016/j.vaccine.2010.12.019 15. Doosti A, Ghasemi- Dehkordi P, Kargar M, Sharifi A. Generation of divalent DNA vaccine based on p39 and shiga-like toxin 2 (Stx2) genes. Genetica. 2015; 47(2): 499-507. doi:10.1016/j.phrp.2015.08.004 16. Doosti A. [Cloning of the gene encoding neurotoxin heavy chain of Clostridium botulinum in E. Coli]. Journal of Microbial World. 2013; 5(3-4): 77-84. [Article in Persian] 17. Hu Z, Ulfendahl M, Olivius NP. NGF stimulates extensive neurite outgrowth from implanted dorsal root ganglion neurons following transplantation into the adult rat inner ear. Neurobiol Dis. 2005 Feb; 18(1): 184-92. doi:10.1016/j.nbd.2004.09.010 18. Michetti P, Kreiss C, Kotloff KL, Porta N, Blanco JL, Bachmann D, et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology. 1999 Apr; 116(4): 804-12. 19. Sutton P, Doidge C, Pinczower G, Wilson J, Harbour S, Swierczak A, et al. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background. FEMS Immunol Med Microbiol. 2007 Jul; 50(2): 213-9. doi:10.1111/j.1574-695X.2006.00206.x 20. Shi Y, Wu C, Zhou WY, Mao XH, Guo G, Zou QM. Identification of H-2d restricted Th epitopes in Urease B subunit of Helicobacter pylori. Vaccine. 2007 Mar; 25(14): 2583-90. doi:10.1016/j.vaccine.2006.12.024 [ DOI] 21. Malfertheiner P, Schultze V, Rosenkranz B, Kaufmann SH, Ulrichs T, Novicki D, et al. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study. Gastroenterology. 2008 Sep; 135(3): 787-95. doi:10.1053/j.gastro.2008.05.054 22. Najar Peerayeh Sh, Atoofi J, Hoseinkhani S, Farshchian M. Cloning and expression of Helicobacter pylori HpaA Gene. Yakhteh Medical Journal. 2009; 11(3): 273-6. 23. Liu KY, Shi Y, Luo P, Yu S, Chen L, Zhao Z, et al. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model. Vaccine. 2011 Sep; 29(38): 6679-85. doi:10.1016/j.vaccine.2011.06.099 24. Gong Y, Tao L, Wang F, Liu W, Jing L, Liu D, et al. Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine. Mol Med Rep. 2015 Sep; 12(3): 4123-32. doi:10.3892/mmr.2015.3950
|